Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study

BACKGROUND: Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM), who are at a greater risk of acute myocardial infarction (AMI) and sudden cardiac death. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ting-Yung, Lu, Chi-Ting, Huang, Hsin-Lei, Chou, Ruey-Hsing, Chang, Chun-Chin, Liu, Chung-Te, Huang, Po-Hsun, Lin, Shing-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098830/
https://www.ncbi.nlm.nih.gov/pubmed/35571176
http://dx.doi.org/10.3389/fcvm.2022.882181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098830/
https://www.ncbi.nlm.nih.gov/pubmed/35571176
http://dx.doi.org/10.3389/fcvm.2022.882181

Ejemplares similares